Genfit Equities

GENFIT Announces Solid H1 2024 Financials and Key Corporate Developments Sep 20, 2024

GENFIT Achieves FDA Approval Milestone with Ipsen's Iqirvo® for Primary Biliary Cholangitis Jun 11, 2024